Neoadjuvant Tebentafusp for Uveal Melanoma

Clinical trial NCT06414590 · RECRUITING

Trial details

NCT number: NCT06414590
Sponsor: Thomas Jefferson University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Unresectable Uveal Melanoma

Start date: 2025-09-05
Primary completion: 2027-08-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.